Edges in Network
Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
Node | STK16 |
Upstream (Parents) |
---|
(<<) BZW1 → STK16 |
(<<) DVL1 → STK16 |
(<<) HLA-G → STK16 |
(<<) ITGB5 → STK16 |
(<<) KCNJ2 → STK16 |
(<<) MAP3K14 → STK16 |
(<<) MKNK2 → STK16 |
(<<) MPP1 → STK16 |
(<<) PAK1 → STK16 |
(<<) PDIA3 → STK16 |
(<<) PKM2 → STK16 |
(<<) RCOR1 → STK16 |
(<<) RHOA → STK16 |
(<<) RHOD → STK16 |
(<<) RPL23A → STK16 |
(<<) SLC29A1 → STK16 |
(<<) SPDEF → STK16 |
(<<) TINF2 → STK16 |
(<<) TSG101 → STK16 |
Downstream (Children) |
---|
STK16 → ADAM17 (>>) |
STK16 → ARSD (>>) |
STK16 → BCL6 (>>) |
STK16 → BZW2 (>>) |
STK16 → CXCL1 (>>) |
STK16 → EFHD2 (>>) |
STK16 → FZD1 (>>) |
STK16 → MMP14 (>>) |
STK16 → PPP2R5B (>>) |
STK16 → PRKCG (>>) |
STK16 → PSORS1C2 (>>) |
STK16 → RDX (>>) |